-
公开(公告)号:US6103236A
公开(公告)日:2000-08-15
申请号:US981416
申请日:1997-11-10
申请人: Toshiyuki Suzawa , Motoo Yamasaki , Satoru Nagamura , Hiromitsu Saito , So Ohta , Nobuo Hanai
发明人: Toshiyuki Suzawa , Motoo Yamasaki , Satoru Nagamura , Hiromitsu Saito , So Ohta , Nobuo Hanai
IPC分类号: A61K39/44 , A61K47/48 , C07K17/06 , A61K39/395 , C07K16/00
CPC分类号: A61K47/48438 , A61K39/44 , A61K47/48407 , A61K47/48715 , C07K17/06
摘要: The present invention relates to a toxin conjugate in which a residue derived from a compound having an affinity for a target cell is bound to a toxin through a spacer comprising polyalkylene glycol and dipeptide.
摘要翻译: PCT No.PCT / JP96 / 01241 Sec。 371日期:1997年11月10日 102(e)1997年11月10日PCT PCT 1996年5月10日PCT公布。 公开号WO96 / 35451 日本1996年11月14日本发明涉及一种毒素结合物,其中衍生自对靶细胞具有亲和力的化合物的残基通过包含聚亚烷基二醇和二肽的间隔物与毒素结合。
-
公开(公告)号:US5621101A
公开(公告)日:1997-04-15
申请号:US486739
申请日:1995-06-07
申请人: Michael E. Lewis , James C. Kauer , Nicola Neff , Jill Roberts-Lewis , Chikara Murakata , Hiromitsu Saito , Yuzuru Matsuda , Marcie A. Glicksman , Fumihiko Kanai , Masami Kaneko
发明人: Michael E. Lewis , James C. Kauer , Nicola Neff , Jill Roberts-Lewis , Chikara Murakata , Hiromitsu Saito , Yuzuru Matsuda , Marcie A. Glicksman , Fumihiko Kanai , Masami Kaneko
IPC分类号: A61K31/407 , A61K31/5377 , A61K31/553 , A61K31/7056 , C07D487/14 , C07D498/22 , C07D519/00 , A61K31/55
CPC分类号: C07D487/14 , A61K31/407 , A61K31/5377 , A61K31/553 , A61K31/7056
摘要: The invention features novel derivatives of K-252a, as well as novel bis-N-substituted derivatives of staurosporine. The invention also features a method for treating diseased neuronal cells involving the administration of either the novel staurosporine derivatives or specified functional derivatives of K-252a.
摘要翻译: 本发明的特征在于K-252a的新衍生物以及星形孢菌素的新型双-N-取代衍生物。 本发明还涉及一种用于治疗患有神经元细胞的方法,涉及施用新型星形孢菌素衍生物或K-252a的特定功能衍生物。
-
公开(公告)号:US5621100A
公开(公告)日:1997-04-15
申请号:US329540
申请日:1994-10-26
申请人: Michael E. Lewis , James C. Kauer , Nicola Neff , Jill Roberts-Lewis , Chikara Murakata , Hiromitsu Saito , Yuzuru Matsuda , Marcie A. Glicksman , Fumihiko Kanai , Masami Kaneko
发明人: Michael E. Lewis , James C. Kauer , Nicola Neff , Jill Roberts-Lewis , Chikara Murakata , Hiromitsu Saito , Yuzuru Matsuda , Marcie A. Glicksman , Fumihiko Kanai , Masami Kaneko
IPC分类号: A61K31/407 , A61K31/5377 , A61K31/553 , A61K31/7056 , C07D487/14 , C07D498/22 , C07D519/00 , A61K31/55
CPC分类号: C07D487/14 , A61K31/407 , A61K31/5377 , A61K31/553 , A61K31/7056
摘要: The invention features novel derivatives of K-252a, as well as novel bis-N-substituted derivatives of staurosporine. The invention also features a method for treating diseased neuronal cells involving the administration of either the novel staurosporine derivatives or specified functional derivatives of K-252a.
摘要翻译: 本发明的特征在于K-252a的新衍生物以及星形孢菌素的新型双-N-取代衍生物。 本发明还涉及一种用于治疗患有神经元细胞的方法,涉及施用新型星形孢菌素衍生物或K-252a的特定功能衍生物。
-
公开(公告)号:US5344926A
公开(公告)日:1994-09-06
申请号:US79560
申请日:1993-06-22
申请人: Chikara Murakata , Toshimitsu Takiguchi , Shigeo Katsumata , Akira Mihara , Keiichi Takahashi , Hiromitsu Saito , Shiro Akinaga , Masami Okabe , Yutaka Saito
发明人: Chikara Murakata , Toshimitsu Takiguchi , Shigeo Katsumata , Akira Mihara , Keiichi Takahashi , Hiromitsu Saito , Shiro Akinaga , Masami Okabe , Yutaka Saito
IPC分类号: C07D498/22 , C07H9/06 , C07H19/04
CPC分类号: C07D498/22 , C07H19/04 , C07H9/06
摘要: Disclosed is a process for producing a staurosporine derivative represented by Formula (I): Q is defined as in specification: ##STR1## The staurosporine derivative (I-1) possesses selective protein kinase C-inhibitory and cell growth-inhibiting activities, and platelet-increasing activity.
摘要翻译: (I)星形孢菌素衍生物(I-1)具有选择性蛋白激酶C抑制和细胞生长抑制活性的方法, ,血小板增多活性。
-
公开(公告)号:US5138059A
公开(公告)日:1992-08-11
申请号:US380379
申请日:1989-07-17
申请人: Keiichi Takahashi , Michio Ichimura , Shigeo Katsumata , Tatsuhiro Ogawa , Makoto Morimoto , Tadashi Ashizawa , Masaji Kasai , Kenichi Muroi , Hiromitsu Saito , Hiroshi Sano , Toru Yasuzawa
发明人: Keiichi Takahashi , Michio Ichimura , Shigeo Katsumata , Tatsuhiro Ogawa , Makoto Morimoto , Tadashi Ashizawa , Masaji Kasai , Kenichi Muroi , Hiromitsu Saito , Hiroshi Sano , Toru Yasuzawa
IPC分类号: C12P17/18 , A61K31/40 , A61K31/435 , A61P31/04 , A61P35/00 , C07D471/04 , C07D487/04 , C12N1/20 , C12R1/465
CPC分类号: C07D471/04 , C07D487/04
摘要: Novel DC-89 compounds represented by the general formula: ##STR1## wherein X represents a single bond or --CH.sub.2 --; and when X represents a single bond, Y represents --CH.sub.2 Br or --CH.sub.2 Cl and when X represents --CH.sub.2 --, Y represents Br, are obtained by the present invention. The compounds have antibacterial and anti-tumor activity.
-
公开(公告)号:US5117006A
公开(公告)日:1992-05-26
申请号:US700507
申请日:1991-05-15
申请人: Hiromitsu Saito , Masaji Kasai , Makoto Morimoto , Eiji Kobayashi , Yoichi Uosaki , Yutaka Kanda , Hiroshi Sano
发明人: Hiromitsu Saito , Masaji Kasai , Makoto Morimoto , Eiji Kobayashi , Yoichi Uosaki , Yutaka Kanda , Hiroshi Sano
IPC分类号: C07D487/04 , C07D487/10
CPC分类号: C07D487/04 , C07D487/10
摘要: A DC-88A derivative represented by general formula: ##STR1## wherein ##STR2## represents ##STR3## has an excellent antitumor activity and is useful as an anti-tumor agent.
-
公开(公告)号:US4946957A
公开(公告)日:1990-08-07
申请号:US400883
申请日:1989-08-30
申请人: Hiromitsu Saito , Yoichi Uosaki , Akira Sato , Tadashi Hirata , Makoto Morimoto , Tadashi Ashizawa
发明人: Hiromitsu Saito , Yoichi Uosaki , Akira Sato , Tadashi Hirata , Makoto Morimoto , Tadashi Ashizawa
IPC分类号: A61K31/495 , A61P31/04 , C07D471/18 , C07D498/22
CPC分类号: C07D471/18 , C07D498/22
摘要: The present invention relates to novel derivatives of DC-52 represented by the following formula (I): ##STR1## [wherein X is chlorine, bromine, iodine, hydroxyl, formyl, hydroxyiminomethyl, cyano, nitro, amino or lower alkanoylamino; and Y is hydroxyl and Z is cyano, or Y and Z represent --O-- in the form of --Y--Z--]. These compounds and pharmacologically acceptable salts thereof have high anti-tumor activity.
-
公开(公告)号:US4822882A
公开(公告)日:1989-04-18
申请号:US102359
申请日:1987-09-29
申请人: Hiromitsu Saito , Yoichi Uosaki , Akira Sato , Tadashi Hirata , Makoto Morimoto , Tadashi Ashizawa
发明人: Hiromitsu Saito , Yoichi Uosaki , Akira Sato , Tadashi Hirata , Makoto Morimoto , Tadashi Ashizawa
IPC分类号: C07D471/18 , C07D498/22 , A61K31/495 , C07D487/18
CPC分类号: C07D471/18 , C07D498/22
摘要: Compounds represented by the following formula or by the corresponding hydroquinone type formula: ##STR1## in which R.sup.1 and R.sup.2 are independently hydrogen, lower alkoxy, azido, amino, lower alkylamino, di-lower alkylamino, cyclic amino, lower alkylthio or unsubstituted or substituted arylthio; and X represents hydroxyl and Y represents cyano or X and Y together represents --O-- in the form of --X--Y--, have an excellent antitumor activity.
-
公开(公告)号:US20100026246A1
公开(公告)日:2010-02-04
申请号:US12507891
申请日:2009-07-23
IPC分类号: H02J7/04
CPC分类号: H02J7/1461 , H02H5/04 , H02H7/125 , H02J7/1492 , Y02T10/92
摘要: A battery charging apparatus includes a controlled rectifier circuit for rectifying an output of a magneto AC generator and supplying a rectified output to a battery. The controlled rectifier circuit includes thyristors as rectifying elements, and components of the controlled rectifier circuit are mounted on a circuit board. The charging apparatus includes a protection circuit which has a sensor detecting a temperature of the circuit board and inhibits a trigger signal from being supplied to thyristors of said rectifier circuit when a temperature detected by said sensor is equal to or higher than a predetermined value.
摘要翻译: 电池充电装置包括可控整流电路,用于对磁电交流发电机的输出进行整流并将整流输出提供给电池。 可控整流电路包括晶闸管作为整流元件,并且可控整流电路的部件安装在电路板上。 所述充电装置包括保护电路,所述保护电路具有检测所述电路板的温度的传感器,并且当所述传感器检测到的温度等于或高于预定值时,禁止将触发信号提供给所述整流电路的晶闸管。
-
公开(公告)号:US5084468A
公开(公告)日:1992-01-28
申请号:US392271
申请日:1989-08-10
申请人: Hiromitsu Saito , Masaji Kasai , Makoto Morimoto , Eiji Kobayashi , Yoichi Uosaki , Yutaka Kanda , Hiroshi Sano
发明人: Hiromitsu Saito , Masaji Kasai , Makoto Morimoto , Eiji Kobayashi , Yoichi Uosaki , Yutaka Kanda , Hiroshi Sano
IPC分类号: C07D487/04 , C07D487/10
CPC分类号: C07D487/04 , C07D487/10
摘要: A novel DC-88A derivative represented by general formula: ##STR1## wherein ##STR2## represents ##STR3## has an excellent antitumor activity and is useful as an antitumor agent.
-
-
-
-
-
-
-
-
-